Trials / Completed
CompletedNCT05370716
Drug-Drug Interaction Study of "CG-651" in Healthy Volunteer
A Randomized, Open-label, Multiple-dose, Parallel Study to Compare the Pharmacokinetics and to Evaluate Drug-Drug Interaction of "CG-651" in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- CrystalGenomics, Inc. · Industry
- Sex
- All
- Age
- 19 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This is randomized , open-label, multiple-dose, parallel study to compare the pharmacokinetics and to evaluate Drug-Drug Interaction of "CG-651" in healthy volunteers.
Detailed description
Total of 39 health volunteers will be randomized to receive either of Group A,B or C. (13 subjects each) \[Group A\] Pregabalin+ Polmacoxib. \[Group B\] Polmacoxib \[Group C\] Pregabalin
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Polmacoxib | Polmacoxib |
| DRUG | Pregabalin | Pregabalin |
Timeline
- Start date
- 2019-11-11
- Primary completion
- 2020-04-30
- Completion
- 2020-05-19
- First posted
- 2022-05-11
- Last updated
- 2022-05-31
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05370716. Inclusion in this directory is not an endorsement.